Related Experiment Video
Updated: Sep 7, 2025

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
Spondyloarthritis in familial Mediterranean fever: a cohort study
Sevtap Acer Kasman1, Mehmet Tuncay Duruöz2
1Sevtap Acer Kasman, Kartal Dr. Lutfi Kirdar City Hospital, Rheumatology Clinic, Istanbul, Turkey. sevtap-acer@hotmail.com.
Abstract:
Familial Mediterranean fever (FMF) and spondyloarthritis (SpA) may show several common signs. This study aimed to evaluate the frequency of SpA and its manifestations in FMF, the impact of SpA on FMF, and the associations of non-episodic findings (heel enthesitis, protracted arthritis, and sacroiliitis) with the FMF features. Demographic, clinical, imaging, and genetic data were retrieved from medical records of the patients with adult FMF. To identify patients who met the classification criteria for SpA, data including rheumatologic inquiry were recorded. Patients with SpA and those who did not meet the criteria were compared in terms of FMF features. Regression analyses were performed to determine the factors that were most associated with sacroiliitis, enthesitis, and protracted arthritis. Of the 283 patients with FMF, 74 (26.1%) met the SpA criteria (64 axial, 10 peripheral); and 65 (22.9%) patients had sacroiliitis, 27 (9.5%) protracted arthritis, and 61 (21.6%) heel enthesitis. Patients with SpA were older and had more FMF severity, and heel pain rate than those without; however, genetic features, CRP, resistance to colchicine, and heel enthesitis did not differ. A meaningful number of patients without SpA had also displayed heel enthesitis, protracted arthritis, inflammatory back pain, heel pain, family history of SpA, and elevated CRP. Age was found to be the main predictor of heel enthesitis and protracted arthritis was linked with FMF severity. A significant number of patients with FMF meet the peripheral SpA classification criteria as well as axial SpA. SpA and its shared manifestations with FMF may have an impact on FMF.
Insights
Familial Mediterranean fever (FMF) often co-occurs with spondyloarthritis (SpA), impacting FMF severity. Many FMF patients meet SpA criteria, highlighting shared inflammatory pathways and the need for comprehensive patient evaluation.
Area of Science:
- Rheumatology
- Internal Medicine
- Genetics
Background:
- Familial Mediterranean fever (FMF) and spondyloarthritis (SpA) share overlapping clinical features.
- Understanding the prevalence and impact of SpA in FMF patients is crucial for comprehensive management.
Purpose of the Study:
- To determine the frequency of SpA and its manifestations in adult FMF patients.
- To assess the impact of SpA on FMF disease severity.
- To investigate associations between non-episodic SpA findings and FMF characteristics.
Main Methods:
- Retrospective analysis of demographic, clinical, imaging, and genetic data from 283 adult FMF patients.
- Classification criteria for SpA were applied, and patients were compared based on SpA status.
- Regression analyses identified predictors for sacroiliitis, enthesitis, and protracted arthritis.
Main Results:
- 74 (26.1%) FMF patients met SpA criteria (64 axial, 10 peripheral).
- Prevalence of sacroiliitis, protracted arthritis, and heel enthesitis was 22.9%, 9.5%, and 21.6%, respectively.
- SpA patients were older, with greater FMF severity and heel pain, but similar genetic profiles and colchicine resistance compared to non-SpA FMF patients.
Conclusions:
- A significant proportion of FMF patients fulfill classification criteria for axial and peripheral SpA.
- SpA and its common manifestations can influence FMF disease course and severity.
- Age is a key predictor for heel enthesitis, while FMF severity is linked to protracted arthritis.
More Related Videos
04:47Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice
Published on: October 27, 2023
12:23Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model
Published on: April 24, 2020
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease III: Medical Management
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Pericarditis I: Introduction